// App-Quantinova.ai

11087 : Benefits of Dabigatran versus Warfarin in Hypertensive Patients With Atrial Fibrillation: Results From The Re-ly Trial

Researchers

Presenter

  • Stuart Connolly

Principal Investigators

  • Martina Brueckmann

  • Robert G Hart

  • Paul Reilly

  • Herbert Noack

  • Andreas Clemens

  • Lars Wallentin

  • Salim Yusuf

  • Michael D Ezekowitz

Medical Centers

  • Uppsala Clinical Research Center, Uppsala, Sweden

  • Jefferson Medical Coll, Wynnewood, PA

  • McMaster University, Hamilton, ON, Canada

  • Electrophysiology Res Fndn, Warren, NJ

  • McMaster University, Hamilton, ON, Canada

Locations

  • United States

  • Canada

  • Sweden

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Arrhythmia

  • Diabetes

  • Congestive heart failure

  • Stroke

Biomarkers

  • GC Vitamin D Binding Protein

  • Sex hormone binding globulin

Drug/Treatment

  • Pradax

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved